首页 | 本学科首页   官方微博 | 高级检索  
检索        

脑源性神经营养因子(BDNF)在多发性骨髓瘤患者血浆中表达增高及其意义的初步研究
引用本文:胡豫,孙春艳,王雅丹,魏文宁,吴涛,何文娟,赵湜.脑源性神经营养因子(BDNF)在多发性骨髓瘤患者血浆中表达增高及其意义的初步研究[J].中国实验血液学杂志,2005,13(1):104-109.
作者姓名:胡豫  孙春艳  王雅丹  魏文宁  吴涛  何文娟  赵湜
作者单位:1. 华中科技大学同济医学院附属协和医院血液病研究所,武汉,430022
2. 武汉市中心医院血液科,武汉,430022
基金项目:湖北省青年杰出人才基金资助,编号2 0 0 3ABB0 17
摘    要:为了研究多发性骨髓瘤 (MM)患者血浆中脑源性神经营养因子 (BDNF)、血管内皮细胞生长因子 (VEGF)的表达情况和BDNF与血管新生的关系 ,初步探讨BDNF在MM的发生与发展中的潜在作用 ,用酶联免疫吸附试验 (ELISA)测定MM患者与健康体检者血浆BDNF和VEGF的浓度 ;采用MTT法观察BDNF对脐静脉内皮细胞(HUVEC)增殖的作用 ;用改良的Boyden小室法和体外小管形成实验等体外血管新生模型观察BDNF对HUVEC迁移和形成血管通道的影响 ;采用鸡胚尿囊膜血管生成实验和小鼠matrigelplug方法观察BDNF对体内血管新生的影响。结果表明 :患者血浆BDNF浓度为 (4.2 2± 0 .6 4 )ng ml,与健康体检者 (2 .0 3± 0 .38)ng ml相比 ,差异有显著性意义 (P =0 .0 10 ) ;患者血浆VEGF浓度为 (79.35± 13.2 5 ) pg ml,与健康体检者 (34.4 1± 1.78)pg ml相比 ,差异有显著性意义 (P =0 .0 0 6 )。BDNF与VEGF水平间存在着相关性 (r =0 .4 30 ,P =0 .0 2 5 )。BDNF对HUVEC的增殖没有显著作用 ,但可明显促进HUVEC的迁移和管状结构形成 ;同时可促进鸡胚尿囊膜血管生成和matrigelplug中血管新生。结论 :MM患者血浆BDNF和VEGF显著增高 ,BDNF在体内外均具有明显的促血管新生效应 ,在MM的血管新生中可能起着重要作用。

关 键 词:脑源性神经营养因子  VEGF  多发性骨髓瘤  血管新生
文章编号:1009-2137(2005)01-0104-06
修稿时间:2004年8月8日

Study on the High Expression of Brain-Derived Neurotrophic Factor in Multiple Myeloma Patients and Its Possible Mechanism
HU Yu,SUN Chun-Yan,WANG Ya-Dan,WEI Wen-Ning,WU Tao,HE Wen-Jun,ZHAO Shi Institute of Hematology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan ,China.Study on the High Expression of Brain-Derived Neurotrophic Factor in Multiple Myeloma Patients and Its Possible Mechanism[J].Journal of Experimental Hematology,2005,13(1):104-109.
Authors:HU Yu  SUN Chun-Yan  WANG Ya-Dan  WEI Wen-Ning  WU Tao  HE Wen-Jun  ZHAO Shi Institute of Hematology  Union Hospital  Tongji Medical College  Huazhong University of Science and Technology  Wuhan  China
Institution:Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. huyu1964@163.net
Abstract:In order to investigate the expression of brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) in multiple myeloma patients and the in vitro and in vivo proangiogenic effects of BDNF, the plasma concentrations of BDNF and VEGF in MM patients and control group were determined by ELISA, the effect of BDNF on the in vitro proliferation of human umbilical vein endothelial cells (HUVEC) was examined by MTT assay; the effects of BDNF on HUVEC migration and tube formation were studied by modified Boyden chamber assay and tube formation assay, respectively. Matrigel plug assay and chorioallantoic membrane assay were used to evaluate the effect of BDNF on angiogenesis in vivo. The results demonstrated that the concentration of BDNF was (4.22 +/- 0.64) ng/ml and (2.03 +/- 0.38) ng/ml in MM group and control group, respectively, (P = 0.01). There was also a significant difference between VEGF levels of two groups (79.35 +/- 13.25) pg/ml vs (34.41 +/- 1.78) pg/ml, P = 0.006]. The levels of BDNF and VEGF correlated significantly (r = 0.430, P = 0.025). BDNF stimulated the migration and tube formation in vitro significantly, although it had no effect on the proliferation of HUVEC. BDNF also stimulated angiogenesis both in matrigel plug of mouse model and in chick chorioallantoic membrane. It is concluded that the concentrations of BDNF and VEGF in MM patients' peripheral blood are at high level; BDNF can stimulate the angiogenesis markedly in vitro and in vivo. Therefore, BDNF may act as an important regulator in angiogenesis of MM.
Keywords:brain-derived neurotropic factor  VEGF  multiple myeloma  angiogenesis
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号